Medicare Enrolled
Dr. Nizar Nader, MD
Critical Care Medicine · Garfield Hts, OH
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Nader from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Nader?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Nader
Dr. Nizar Nader is a critical care medicine specialist in Garfield Hts, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. Nader performed 1,911 Medicare services across 1,169 unique beneficiaries.
Between the years covered by Open Payments, Dr. Nader received a total of $15,065 from 59 pharmaceutical and/or device companies across 877 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in critical care medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Nader is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 4% volume in OH
$15,065 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,911
Medicare services
Top 4% in OH for critical care medicine
1,169
Unique beneficiaries
$67
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~96 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
713 | $87 | $174 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
171 | $90 | $125 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
170 | $26 | $150 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
167 | $121 | $315 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
143 | $40 | $100 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
132 | $32 | $125 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
110 | $9 | $35 |
| Breathing device use evaluation An assessment of how a patient uses a breathing device. The provider reviews the patient's technique and device handling. |
55 | $12 | $25 |
| Quadrivalent influenza vaccine, cell culture-derived A flu shot that protects against four strains of the influenza virus. It is produced using cell culture technology rather than traditional egg-based methods. |
53 | $32 | $40 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
52 | $24 | $25 |
| New patient office visit, complex (60-74 min) | 34 | $152 | $258 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
31 | $95 | $145 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
21 | $4 | $15 |
| Inhalation treatment for airway obstruction or sputum production A treatment involving the inhalation of medication to help clear airway obstructions or reduce sputum production. |
17 | $6 | $35 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
16 | $24 | $25 |
| Pneumococcal vaccine, 23-valent A vaccine that protects against 23 types of pneumococcal bacteria. It is used to prevent infections caused by these bacteria. |
15 | $131 | $135 |
| Initial nursing facility care, moderate complexity Initial care provided to a patient in a nursing facility with moderate medical decision making, taking at least 35 minutes. |
11 | $102 | $188 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$15,065
Total received (2018-2024)
Avg $2,152/year across 7 years
Top 8% in OH for critical care medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
59
Companies
877
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,965 (99.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$100 (0.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,336
2023
$2,483
2022
$2,529
2021
$2,113
2020
$1,686
2019
$1,992
2018
$1,926
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Inspire Medical Systems, Inc.
$362
AstraZeneca Pharmaceuticals LP
$337
GlaxoSmithKline, LLC.
$336
GENZYME CORPORATION
$173
Takeda Pharmaceuticals U.S.A., Inc.
$131
HARMONY BIOSCIENCES LLC
$110
United Therapeutics Corporation
$87
Merck Sharp & Dohme LLC
$85
Mylan Specialty L.P.
$66
JAZZ PHARMACEUTICALS INC.
$65
Genentech USA, Inc.
$63
PFIZER INC.
$60
Grifols USA, LLC
$58
Philips North America LLC
$53
Boehringer Ingelheim Pharmaceuticals, Inc.
$48
Regeneron Healthcare Solutions, Inc.
$47
Amgen Inc.
$42
Insmed, Inc.
$42
Optinose US, Inc.
$39
Actelion Pharmaceuticals US, Inc.
$26
Electromed, Inc.
$25
Baxter Healthcare
$19
Janssen Pharmaceuticals, Inc
$18
ANI Pharmaceuticals, Inc.
$16
INOGEN, INC.
$15
Harmony Biosciences Llc
$15
Top 3 companies account for 44.3% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$3,489
AstraZeneca Pharmaceuticals LP
$2,039
GENZYME CORPORATION
$1,273
Boehringer Ingelheim Pharmaceuticals, Inc.
$747
Regeneron Healthcare Solutions, Inc.
$713
Genentech USA, Inc.
$689
Actelion Pharmaceuticals US, Inc.
$569
Inspire Medical Systems, Inc.
$362
Teva Pharmaceuticals USA, Inc.
$353
Philips Electronics North America Corporation
$329
Electromed, Inc.
$323
Mylan Specialty L.P.
$290
Novartis Pharmaceuticals Corporation
$289
PFIZER INC.
$270
Amgen Inc.
$253
United Therapeutics Corporation
$238
Takeda Pharmaceuticals U.S.A., Inc.
$229
JAZZ PHARMACEUTICALS INC.
$216
Medtronic USA, Inc.
$166
Inogen, Inc.
$154
Circassia Pharmaceuticals Inc
$132
Merck Sharp & Dohme LLC
$112
HARMONY BIOSCIENCES LLC
$110
Bayer HealthCare Pharmaceuticals Inc.
$103
TETRAPHASE PHARMACEUTICALS, INC.
$102
Janssen Pharmaceuticals, Inc
$98
Grifols USA, LLC
$96
SANOFI-AVENTIS U.S. LLC
$94
Baxter Healthcare
$94
Jazz Pharmaceuticals Inc.
$82
Axsome Therapeutics, Inc.
$81
Mallinckrodt Hospital Products Inc.
$74
CSL Behring
$73
Mallinckrodt LLC
$64
Melinta Therapeutics, Inc.
$62
Insmed, Inc.
$60
Gilead Sciences, Inc.
$57
Philips North America LLC
$53
Mallinckrodt Enterprises LLC
$51
Paratek Pharmaceuticals, Inc.
$48
Advanced Respiratory, Inc
$48
Sunovion Pharmaceuticals Inc.
$42
Optinose US, Inc.
$39
Harmony Biosciences LLC
$34
La Jolla Pharmaceutical Company
$33
E.R. Squibb & Sons, L.L.C.
$27
Pharming Healthcare, Inc.
$24
Alexion Pharmaceuticals, Inc.
$18
Bayer Healthcare Pharmaceuticals Inc.
$18
Allergan Inc.
$17
ANI Pharmaceuticals, Inc.
$16
Shionogi Inc
$15
INOGEN, INC.
$15
Harmony Biosciences Llc
$15
ADVANCED RESPIRATORY, INC
$15
Merck Sharp & Dohme Corporation
$14
Phadia US Inc.
$14
Nabriva Therapeutics, plc
$14
Covis Pharma GmBH
$12
Top 3 companies account for 45.1% of all-time payments
Associated products mentioned in payments ›
(2791) CoughAssist · (8874) inCourage · (AK6) Vest Therapy · ACTHAR · AIRSUPRA · ALVESCO · ANORO · ANORO ELLIPTA · AREXVY · AVYCAZ · Adempas · Aimovig · AirDuo Digihaler · Arikayce · BREO · BREO ELLIPTA · BREZTRI · BREZTRI AEROSPHERE · CINQAIR · CUTAQUIG · CUVITRU · DUAKLIR PRESSAIR · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ELIQUIS · Esbriet · FASENRA · Fetroja · GLASSIA · HYQVIA · Hillrom - Monarch Airway Clearance System · Hillrom - Vest System Model 105 Home Care · Hizentra · INOGEN · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · INSPIRE · INTERSTIM · INVOKANA · ImmunoCAP · InogenOne · KEYTRUDA · NUCALA · NUZYRA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OPSUMIT · OPSUMIT MACITENTAN · PANZYGA · PURIFIED CORTROPHIN GEL · Perforomist · ProAir Digihaler · Prolastin-C Liquid · RUCONEST · Respiratoriy Care Undiv · S&RC Und · SEEBRI · SHINGRIX · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Soliris · Sunosi · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · UPTRAVI · VERQUVO · Vabomere · WAKIX · WINREVAIR · Wakix · XARELTO · XERAVA · XOLAIR · XYWAV · Xenleta · Xerava · Xhance · Xofluza · Xolair · YUPELRI · Yupelri · ZERBAXA · Zemaira · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 8% for critical care medicine in OH.
Geographic Context
Critical care medicines within 10 mi
59
Per 100K population
4.7
County median income
$62,823
Nearest hospital
MARYMOUNT HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Nader is a clinical cardiology specialist, with above-average Medicare volume (top 4% in OH), with low-engagement industry engagement in the top 8% of OH peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Nader experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Nader performed 713 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Nader receive payments from pharmaceutical companies?
Yes. Dr. Nader received a total of $15,065 from 59 companies across 877 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Nader's costs compare to other critical care medicines in Garfield Hts?
Dr. Nader's average Medicare payment per service is $67. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Nader) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Critical Care Medicines in Garfield Hts
Browse critical care medicines in Garfield Hts ranked by procedure volume and transparency data.
Highest volume
Top Critical Care Medicines in OH
Critical care medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Critical Care Medicines in OH
Which OH critical care medicines receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology